OraSure Technologies (OSUR) : During the past 4 weeks, traders have been relatively bearish on OraSure Technologies (OSUR), hence the stock is down -8.11% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -4.25% relative to the S&P 500. The 4-week change in the price of the stock is -8.6% and the stock has fallen -4.09% in the past 1 week.
The stock has recorded a 20-day Moving Average of 6.16% and the 50-Day Moving Average is 3.77%.The 200 Day SMA reached 14.69%
OraSure Technologies (NASDAQ:OSUR): After opening at $7.95, the stock dipped to an intraday low of $7.8 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $7.99 and the buying power remained strong till the end. The stock closed at $7.97 for the day, a gain of 1.01% for the day session. The total traded volume was 670,533. The stocks close on the previous trading day was $7.97.
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.